In our previous work, we demonstrated that the pre-clinical anti-obesity effect of the probiotic BPL1TM, the postbiotic BPL1TM HT and the purified LTA from BPL1TM was dependent on the insulin/IGF-1 signaling pathway [9,10]. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.